# INBIOS INTERNATIONAL, INC.: Development of a sensitive Point-of-Care immunoassay for tick- borne spotted fever group rickettsioses

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | INBIOS INTERNATIONAL, INC. |
| Location | Seattle, WA |
| Project | Development of a sensitive Point-of-Care immunoassay for tick- borne spotted fever group rickettsioses |
| Project number | 1R41AI197509-01 |
| Mechanism | R41 |
| Institute | National Institute of Allergy and Infectious Diseases |
| Award | $314,363 |
| Awarded | 2026-09-08 |
| Project period | 2026-09-08 to 2028-08-31 |
| UEI | CNJNQ1GMSN55 |

## Why this score
- Award of $314,363.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11313004). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.